Business Wire

MAVENIR

14.12.2021 09:03:17 CET | Business Wire | Press release

Share
Vodafone and Mavenir Complete First Call Over Containerised Open RAN Solution

Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, announced today that Vodafone and Mavenir have completed the first data and Voice over LTE (VoLTE) call across a containerised 4G small cell Open RAN solution in a lab environment. The completed tests are the latest steps forward to delivering an open and vendor-interoperable 4G connectivity solution for small to medium-sized office locations.

Having first started work on a containerised indoor enterprise connectivity solution in January 2021, Vodafone has completed tests for an important stage of the technology roadmap. The plug-and-play small cell equipment can ensure comprehensive mobile coverage in every corner of the office. The solution will provide 4G coverage initially, making use of radio hardware from Sercomm and software from Mavenir (Open RAN).

This demonstration of a containerised solution is a major milestone in the evolution of connectivity equipment away from physical infrastructure to a digital cloud-based environment. Containerisation provides greater flexibility for customers, but also significant benefits in terms of speed and cost of deployment.

Containerisation means that software can be seamlessly transferred between equipment, platforms, and applications. Wind River provided its Containers as a Service (CaaS) software, part of Wind River Studio.

Moving forward, Vodafone and Mavenir will focus on finalising the packaging and automation of the solution before beginning trials with selected customers.

Open RAN technology separates software from hardware, meaning more flexibility for mobile operators and customers. The approach will see many companies providing the components that make up a mobile network site, where previously one vendor would have delivered the whole solution. The technology is widely accepted as a disruptor for the telecommunications industry, and Vodafone is one of the industry leaders in supporting the development of this vendor ecosystem.

Whereas much of the focus for Open RAN has been directed towards network infrastructure deployment on mobile sites throughout the UK, the technology can be implemented in an enterprise environment to support local connectivity requirements. As an interoperable and standardised technology, Open RAN solutions can be integrated with little disruption in a “plug and play” manner, interoperable with other Open RAN compliant vendors.

Andrea Dona, Chief Network Officer, Vodafone UK, said ; “Open RAN is opening doors to simplified and intuitive connectivity solutions. For our wider network deployment strategy, Open RAN is enabling us to work with a wider pool of suppliers and to avoid vendor lock-in scenarios that might prevent us from taking advantage of the latest innovations. The same could be said for enterprise connectivity solutions.

“From the moment Open RAN is deployed in an office environment, customers are no-longer locked into a single upgrade path. Working alongside Vodafone, customers can be more flexible in how connectivity solutions are adapted and upgraded as demands evolve in the future.”

Stefano Cantarelli, Executive Vice President and Chief Marketing Officer, Mavenir, said ; “Cloud Native and Open Solutions are becoming the new reality of the mobile world, and these include Radio Access and its containerised implementation. Open vRAN is a very flexible architecture that can serve any type of segment and Mavenir is really pleased to work with Vodafone in the enterprise business and achieved another first together. It is an opportunity to show that automated and AI controlled systems will simplify life to business and industry.”

About Mavenir:

Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industry's only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 250+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers. www.mavenir.com

About Vodafone UK

Vodafone UK is a technology communications company that connects people, businesses and devices to help our customers benefit from digital innovation. Our services span mobile, fixed-line connections, home and office broadband, and the Internet of Things (IoT). www.vodafone.co.uk

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye